Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_assertion type Assertion NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_head.
- NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_assertion description "[This study evaluated the potential of recombinant pen-2 (rPen-2) in the selective killing of kidney cancer cell lines ACHN and A498, and its action mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_provenance.
- NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_assertion evidence source_evidence_literature NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_provenance.
- NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_assertion SIO_000772 25135722 NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_provenance.
- NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_assertion wasDerivedFrom befree-2016 NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_provenance.
- NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_assertion wasGeneratedBy ECO_0000203 NP1211806.RA1OrVtXgq8i5geqtRuB58rqKoMbjNAb-2Gn3Q-SfDeW0130_provenance.